As Visa (V) Market Valuation Rose, National Asset Management Cut Holding; Horan Capital Advisors Upped Holding in Abbvie (ABBV) by $3.47 Million as Market Valuation Declined

May 22, 2018 - By Marie Mckinney

AbbVie Inc. (NYSE:ABBV) Logo

Horan Capital Advisors Llc increased its stake in Abbvie Inc (ABBV) by 68.35% based on its latest 2017Q4 regulatory filing with the SEC. Horan Capital Advisors Llc bought 27,087 shares as the company’s stock declined 6.31% with the market. The institutional investor held 66,717 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $8.55M, up from 39,630 at the end of the previous reported quarter. Horan Capital Advisors Llc who had been investing in Abbvie Inc for a number of months, seems to be bullish on the $168.57 billion market cap company. It closed at $106.23 lastly. It is up 39.20% since May 22, 2017 and is uptrending. It has outperformed by 27.65% the S&P500.

National Asset Management Inc decreased its stake in Visa Inc (V) by 41.22% based on its latest 2017Q4 regulatory filing with the SEC. National Asset Management Inc sold 22,333 shares as the company’s stock rose 4.18% while stock markets declined. The institutional investor held 31,842 shares of the business services company at the end of 2017Q4, valued at $3.63 million, down from 54,175 at the end of the previous reported quarter. National Asset Management Inc who had been investing in Visa Inc for a number of months, seems to be less bullish one the $292.76 billion market cap company. The stock increased 0.04% or $0.05 during the last trading session, reaching $130.71. About 6.46M shares traded. Visa Inc. (NYSE:V) has risen 31.98% since May 22, 2017 and is uptrending. It has outperformed by 20.43% the S&P500.

Analysts await Visa Inc. (NYSE:V) to report earnings on July, 19. They expect $1.10 EPS, up 27.91% or $0.24 from last year’s $0.86 per share. V’s profit will be $2.46 billion for 29.71 P/E if the $1.10 EPS becomes a reality. After $1.11 actual EPS reported by Visa Inc. for the previous quarter, Wall Street now forecasts -0.90% negative EPS growth.

National Asset Management Inc, which manages about $740.07M US Long portfolio, upped its stake in Boulder Growth & Income Fd I (BIF) by 658,829 shares to 720,188 shares, valued at $7.99M in 2017Q4, according to the filing. It also increased its holding in Ishares Tr (VLUE) by 5,565 shares in the quarter, for a total of 37,277 shares, and has risen its stake in Vanguard Bd Index Fd Inc (BSV).

Investors sentiment increased to 1.05 in Q4 2017. Its up 0.05, from 1 in 2017Q3. It improved, as 55 investors sold V shares while 605 reduced holdings. 141 funds opened positions while 552 raised stakes. 1.61 billion shares or 1.83% less from 1.64 billion shares in 2017Q3 were reported. Stralem & Incorporated reported 3.4% of its portfolio in Visa Inc. (NYSE:V). Inspirion Wealth Advisors Ltd Liability Corp reported 2,115 shares. The Illinois-based Prudential Public Limited Company has invested 0.86% in Visa Inc. (NYSE:V). Pekin Singer Strauss Asset Management Il has 0.3% invested in Visa Inc. (NYSE:V) for 14,510 shares. Klingenstein Fields & Co Limited Com stated it has 0.1% of its portfolio in Visa Inc. (NYSE:V). Schwab Charles Invest Mgmt holds 6.25 million shares. South State reported 81,662 shares or 1.01% of all its holdings. Thomas Story & Son Lc invested in 6.7% or 102,790 shares. Tradewinds Cap Limited Liability Com stated it has 0.28% of its portfolio in Visa Inc. (NYSE:V). Moreover, Balyasny Asset Mngmt has 0.51% invested in Visa Inc. (NYSE:V) for 1.42 million shares. Axa owns 1.87 million shares. Family Mgmt Corp owns 36,710 shares. E&G Limited Partnership holds 5,308 shares. Winslow Asset Incorporated accumulated 2,550 shares. Riverhead Capital Management Ltd Co holds 0.19% or 39,593 shares in its portfolio.

Since December 13, 2017, it had 0 insider buys, and 5 insider sales for $12.69 million activity. MAHON TULLIER KELLY sold $5.65 million worth of Visa Inc. (NYSE:V) on Friday, December 15. MATSCHULLAT ROBERT W had sold 6,220 shares worth $707,561. HOFFMEISTER JAMES H had sold 8,423 shares worth $1.08M on Monday, April 30. MCINERNEY RYAN sold $5.06M worth of stock or 38,500 shares.

Among 43 analysts covering Visa Inc. (NYSE:V), 34 have Buy rating, 0 Sell and 9 Hold. Therefore 79% are positive. Visa Inc. had 131 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Buy” rating by Mizuho on Thursday, January 4. The company was maintained on Friday, February 2 by Barclays Capital. The rating was maintained by Morgan Stanley with “Overweight” on Thursday, January 25. Piper Jaffray maintained the shares of V in report on Thursday, February 1 with “Buy” rating. The firm has “Buy” rating by Stifel Nicolaus given on Tuesday, October 25. On Monday, October 2 the stock rating was maintained by Robert W. Baird with “Outperform”. The company was downgraded on Tuesday, July 28 by S&P Research. The firm earned “Buy” rating on Friday, June 23 by Jefferies. The firm earned “Buy” rating on Friday, February 2 by BMO Capital Markets. The stock has “Buy” rating by KeyBanc Capital Markets on Wednesday, December 13.

More news for Visa Inc. (NYSE:V) were recently published by: 247Wallst.com, which released: “Can Visa Deliver Another Earnings Beat?” on April 25, 2018. Seekingalpha.com‘s article titled: “Is It Too Late To Buy Visa Stock?” and published on May 17, 2018 is yet another important article.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Investorplace.com which released: “3 Stocks to Buy to Find Gains in Today’s Market” on May 22, 2018, also Seekingalpha.com with their article: “AbbVie Is Still A One-Trick Pony” published on April 26, 2018, 247Wallst.com published: “Why One Old Stock Buyback Trick Is Working So Well for AbbVie” on May 01, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “Biotechs perk up ahead of ASCO abstract drop” published on May 16, 2018 as well as Seekingalpha.com‘s news article titled: “AbbVie: Can Mylan Pull Off A Humira Biosimilar?” with publication date: May 01, 2018.

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.05, from 0.85 in 2017Q3. It is negative, as 42 investors sold ABBV shares while 695 reduced holdings. 139 funds opened positions while 448 raised stakes. 1.06 billion shares or 0.35% more from 1.06 billion shares in 2017Q3 were reported. Portland Advisors Llc holds 0.09% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 2,482 shares. Bsw Wealth Ptnrs accumulated 2,866 shares. Tru Department Mb Financial Bank N A holds 0.34% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 33,193 shares. Moreover, Oakwood Capital Lc Ca has 1.29% invested in AbbVie Inc. (NYSE:ABBV) for 60,291 shares. Stratford Consulting Limited Liability Co accumulated 3,418 shares. Davis R M reported 30,516 shares. Boston Private Wealth Limited Liability owns 435,696 shares. Us Comml Bank De invested 0.86% of its portfolio in AbbVie Inc. (NYSE:ABBV). Harvest invested 0.13% in AbbVie Inc. (NYSE:ABBV). The California-based Diligent Invsts Ltd has invested 0.54% in AbbVie Inc. (NYSE:ABBV). Fruth Investment Mgmt invested 1.49% in AbbVie Inc. (NYSE:ABBV). Roundview Cap Ltd Llc reported 14,487 shares. Coho Prns holds 0.01% or 2,621 shares in its portfolio. Virtu Ltd Co holds 17,117 shares. Cobblestone Capital Advsrs Ny has invested 0.16% in AbbVie Inc. (NYSE:ABBV).

Since December 14, 2017, it had 0 insider buys, and 11 insider sales for $47.70 million activity. Shares for $8.31M were sold by CHASE WILLIAM J on Wednesday, February 28. 992 AbbVie Inc. (NYSE:ABBV) shares with value of $119,351 were sold by Michael Robert A.. RICHMOND TIMOTHY J. sold $2.15M worth of stock. 25,000 AbbVie Inc. (NYSE:ABBV) shares with value of $2.95M were sold by Schumacher Laura J. GONZALEZ RICHARD A had sold 8,280 shares worth $976,084 on Wednesday, February 28. 83,574 shares were sold by ALBAN CARLOS, worth $9.57M on Wednesday, February 28.

Among 23 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 11 Hold. Therefore 43% are positive. Abbvie Inc had 91 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Hold” rating by Deutsche Bank on Tuesday, March 15. The stock has “Buy” rating by Jefferies on Monday, June 26. The firm earned “Buy” rating on Friday, March 10 by Goldman Sachs. As per Monday, November 20, the company rating was maintained by Cowen & Co. The rating was maintained by Jefferies on Monday, February 26 with “Buy”. As per Wednesday, April 19, the company rating was maintained by BMO Capital Markets. The firm earned “Buy” rating on Tuesday, January 16 by Jefferies. The stock of AbbVie Inc. (NYSE:ABBV) has “Market Perform” rating given on Thursday, November 16 by BMO Capital Markets. The company was downgraded on Monday, June 6 by Cowen & Co. The company was maintained on Friday, March 23 by BMO Capital Markets.

Visa Inc. (NYSE:V) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Marie Mckinney

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts